GaviLyte -C (Polyethylene Glycol 3350, 240 g) and electrolytes for Oral Solution, USP with flavor pack NDC# 43386-060-19
Published May 25, 2022 · Recall initiated: April 27, 2022
Summary
FDA records drug Class II recall D-0875-2022, published May 25, 2022 and initiated April 27, 2022. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 26,910 bottles; Lot: Lot # S001132, exp. date July 2022 NDC # 43386-060-19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Stability Specification
What to do
Voluntary: Firm initiated · Letter
Get an email if GAVILYTE - C has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- GAVILYTE - C
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Distributor
- Product was distributed nationwide, including Puerto Rico.
- Lot
- Lot # S001132, exp. date July 2022 NDC # 43386-060-19
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAccupril (Quinapril HCl Tablets) 40 mg, 90 Tablets, Rx only NDC 0071-0535-23 Distributed by: Parke-DavisMay 25, 2022
- FDAPhenobarbital Elixir, USP 20 mg/5 mL, 1 Pint (473 mL) bottles, Rx Only, Manufactured for: WestminsterMay 25, 2022
- FDAAccupril (Quinapril HCl Tablets) 20 mg, 90 Tablets, Rx only NDC 0071-0532-23 Distributed by: Parke-DavisMay 25, 2022
- FDAOpen Nature Cough Drops Menthol-Cough Suppressant/Oral Anesthetic Peppermint Naturally Flavored, packaged inMay 25, 2022
- FDAAccupril (Quinapril HCl Tablets) 10 mg, 90 Tablets Rx only NDC 0071-0530-23 Distributed by: Parke-DavisMay 25, 2022
- FDANitrofurantoin Capsules, USP (Monohydrate/Macrocrystals), 100 mg, 100 Capsules (10 x 10), 10-count blistersMay 25, 2022
Questions about this recall
Was GaviLyte -C (Polyethylene Glycol 3350, 240 g) and electrolytes for Oral Solution, USP with flavor pack NDC# 43386-060-19 recalled?
Yes. FDA published recall D-0875-2022 on May 25, 2022. Reported hazard: Failed Stability Specification
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: GAVILYTE - C.